| 000 | 01467 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515040036.0 | ||
| 264 | 0 | _c20061012 | |
| 008 | 200610s 0 0 tur d | ||
| 022 | _a0494-1373 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCok, Gürsel | |
| 245 | 0 | 0 |
_a[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients]. _h[electronic resource] |
| 260 |
_bTuberkuloz ve toraks _c2006 |
||
| 300 |
_a161-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitomycin _xadministration & dosage |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTurkey |
| 700 | 1 | _aGöksel, Tuncay | |
| 700 | 1 | _aSoyer, Serdar | |
| 700 | 1 | _aAtil, Hülya | |
| 700 | 1 | _aGüzelant, Asuman | |
| 700 | 1 | _aAysan, Tülin | |
| 773 | 0 |
_tTuberkuloz ve toraks _gvol. 54 _gno. 2 _gp. 161-7 |
|
| 999 |
_c16510880 _d16510880 |
||